Advances in Pharmacotherapy of Oral Mucosa Diseases
Authors:
R. Slezák; Z. Šustová; V. Nováková
Authors‘ workplace:
Stomatologická klinika LF UK a FN, Hradec Králové
Published in:
Česká stomatologie / Praktické zubní lékařství, ročník 109, 2009, 1, s. 7-13
Category:
Comprehensive Report
Overview
In this review are characterized some new drugs useful in the treatment of diseases of the oral mucosa. They are Gelclair®, imiquimod and tacrolimus for topical use only and mycophenolate mofetil, voriconazole, posaconazole and valganciclovir for systemic administration.
Key words:
oral mucosa - pharmacotherapy
Sources
1. Bagg, J., Sweeney, M. P., Davies, A. N., Jackson, M. S., Brailsford, S.: Voriconazole susceptibility of yeasts isolated from the mouths of patients with advanced cancer. J. Med. Microbiol., roč. 54, 2005, s. 959-964.
2. Baker, R.: Posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in HIV patients. In: http://www.hivandhepatitis.com.
3. Burn, K., Fothergill, A. W., Kirkpatrick, W. R., Coco, B. J., Patterson, T. F., McCarthy, D. I., Rinaldi, M. G., Redding, S. W.: Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients. J. Clin. Microbiol., roč. 42, 2004, č. 12, s. 5846-5848.
4. Hodgson, T. A., Sahni, N., Kaliakatsou, F., Buchanan, J. A. G., Porter, S. R.: Long-term efficacy and safety of topical tacrolimus in the management of ulcerativeerosive oral lichen planus. Eur J. Dermatos., roč. 13, 2003, č. 5, s. 466-470.
5. http://www.gelclair.co.uk
6. Kovandová, H.: Imiquimod v terapii kožních onemocnění. Derm. Praxi, roč. 1, 2007, č. 4, s. 188-190.
7. Krejsek, J., Kopecký, O.: Modulace imunitního systému (kap.). In: Krejsek. J., Kopecký, O.: Klinická imunologie, Hradec Králové. Nucleus HK, 2004, s. 804-810.
8. Lener, E. V., Brieva, J., Schachter, M., West, L. E., West, D. P.: Successful treatment of erosive lichen planus with topical tacrolimus. Arch. Dermatos., roč. 137, 2001, č. 4, s. 419-422.
9. Ojha, J., Islam, N.; Cohen, D. M., Marsal, D., Reavis, M. R., Bhattacharyya, I.: Post-transplant lymphoproliferative disorders of oral cavity. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., roč. 105, 2008, č. 5, s. 589-596.
10. Smith, K. J., Germain, M., Yeager, J., Skeleton, H.: Topical 5% imiquimod for the therapy of actinic cheilitis. J. Amer. Acad. Dermatol, roč. 47, 2002, 4, s. 497-501.
11. Thoma-Uszynski, S., Eming, R.: Novel therapeutic approaches in autoimmune skin disorders (kap.). In: Hertl, M. (Ed): Autoimmune diseases of the skin. Pathogenesis, diagnosis, management. Springer, Wien New York, 2. vyd., 2005, s. 421-456.
12. Vazquez, J. A., Siest, D. J., Nieto, L., Northland, R., Sanne, I., Gogate, J., Greaves, W., Isaacs, R.: A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. Clin. Infect Dis, roč. 42, 2006, s. 1179-1186.
13. Vokurka, S.: Mukositida dutiny ústní u pacientů po chemoterapii. Kompendium ambulantní medicíny. Medical Tribune, roč. 7, 2008, č. 10/3 2008, s. 8.
14. Weberová, J., Vobořil, R., Semecký, V.: Mycophenolat mofetil, nové perspektivní imunosupresivum. Čes. slov. Farm., roč. 51, 2002, č. 5: s. 220-225.
Labels
Maxillofacial surgery Orthodontics Dental medicineArticle was published in
Czech Dental Journal
2009 Issue 1
Most read in this issue
- Disc Plication as an Operation Method of Temporomandibular Joint Disc Dislocation
- Dental Transplantation
- Advances in Pharmacotherapy of Oral Mucosa Diseases
- Sonic Techniques of Preparation of Hard Dental Tissue